David Sloan, PhD

David Sloan is the Senior Vice President, Life Sciences at RedShift Bio. He has worked in the biotechnology industry for the past 20 years and has always focused on customer satisfaction.  David is most interested in learning about new research areas and developing novel applications on cutting edge technology platforms to solve real world problems. David received his PhD from Duke University Medical Center in the Department of Pharmacology and Cancer Biology, and studied protein-protein interactions with the goal of identifying novel therapeutics. His bachelor’s degree is from Cornell University, with dual degrees in Biology and Chemistry.